Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine for delirium reduction after hip fracture surgery
NL-OMON54044Phase 4Completed
- Sponsor
- Maasstad Ziekenhuis
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of morphine in delirium (2 arms), sponsored by Maasstad Ziekenhuis. Primary endpoint: Incidence of delirium during hospital admission. Started Mar 2022; status: completed.
02
Drugs
morphine
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON54044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54044.